|Year : 2019 | Volume
| Issue : 1 | Page : 125-129
Myositis associated with Salmonella paratyphi A bacteremia appears to be common
Adline Harris1, Stalin Viswanathan1, Rajeswari Aghoram2
1 Department of General Medicine, Indira Gandhi Medical College and Research Institute, Puducherry, India
2 Department of Neurology, JIPMER, Puducherry, India
|Date of Web Publication||31-Jan-2019|
Dr. Stalin Viswanathan
Department of General Medicine, Indira Gandhi Medical College and Research Institute, Puducherry - 605 009
Source of Support: None, Conflict of Interest: None
Background: Fever and severe myalgia in a tropical country like India bring to mind leptospirosis, rickettsioses, dengue, and other viral fevers. Enteric fever is widely prevalent in Asia, but myositis has not been previously described in Salmonella paratyphi A bacteremia. Materials and Methods: Retrospectively, we recruited patients with enteric fever admitted to our treating unit over a 6-month period. Demography, historical, clinical, and laboratory data were obtained. Data of culture-positive S. paratyphi A patients were analyzed and were compared with those patients with culture-negative enteric fever. Results: Forty-three cases were found in total with 19 of S. paratyphi A bacteremia. Elevations in creatine kinase (CK) ranged from one-and-half to six times normal. Forty-seven percent had thrombocytopenia and alanine transaminase elevations, while aspartate transaminase elevations were seen in 17 patients, which corresponded to those with elevated CK levels. Conclusions: Myositis associated with S. typhi and S. paratyphi is very rare and is more often due to non-typhoidal Salmonellae. Elevated creatine kinase was seen in most of our patients with S. paratyphi A bacteremia. Such myositis has not been described previously and hence, myalgia with fever in a tropical country could be a harbinger of paratyphoid fever.
Keywords: Enteric fever, myositis, neurological complications, paratyphoid fever, typhoid fever
|How to cite this article:|
Harris A, Viswanathan S, Aghoram R. Myositis associated with Salmonella paratyphi A bacteremia appears to be common. J Family Med Prim Care 2019;8:125-9
|How to cite this URL:|
Harris A, Viswanathan S, Aghoram R. Myositis associated with Salmonella paratyphi A bacteremia appears to be common. J Family Med Prim Care [serial online] 2019 [cited 2019 Jun 17];8:125-9. Available from: http://www.jfmpc.com/text.asp?2019/8/1/125/251127
| Introduction|| |
The typhoidal Salmonella More Detailse are Salmonella enterica serovar Typhi (S. typhi) and Salmonella enterica serovar Paratyphi A (S. paratyphi A), B, and C. These typhoidal Salmonellae belong to the S. enterica subspecies I of S enterica that also includes S Typhimurium causing gastroenteritis and S Choleraesius that causes invasive bacteremia. S. paratyphi infections have begun replacing S. typhi as the predominant cause of enteric fever. Indian studies have shown surges in S. paratyphi isolates from patients with enteric fever. The five manifestations of Salmonella infections are enteric fever, chronic carriage, gastroenteritis, bacteremia, and focal infections. The latter three arise due to non-typhoidal Salmonellae like S. typhimurium. Salmonella-related muscle involvement is usually in the form of rhabdomyolysis, polymyositis, and pyomyositis. The most common organism causing focal muscle infections is S. enteritidis. Typhoid-related myositis was rare even in Osler's series of 829 (1/829). S. typhi has been reported to cause rhabdomyolysis (>20 cases) and focal abscesses. S. paratyphi is the most common serovar of the paratyphoid group. S. paratyphi A has never previously been reported to cause myositis or acute kidney injury. We report 18 patients of S. paratyphi bacteremia-associated myositis who had been treated in our medical unit over a period of 6 months.
| Materials and Methods|| |
After obtaining approval from the Institute Ethics Committee (IEC/PP/2016/44), data were retrospectively collected from consecutive patients admitted to the Department of Medicine, Indira Gandhi Medical College & Research Institute, between 01 February 2016 and 31 July 2016. All patients ≥13 years with a discharge diagnosis of either “Enteric fever,” “Typhoid fever,” or “Paratyphoid fever” were recruited. Demographic data, medical history, and clinical findings were noted. Laboratory data such as liver function tests (LFT), creatine kinase (CK), Widal, and blood culture reports were obtained. Patients with S. paratyphi A bacteremia were considered as cases. Those with symptoms and four-fold elevations in Widal (S. typhi or S. paratyphi), or a single admission titer of 1:320 were taken as culture-negative enteric fever. A symptom-complex of myalgia with or without objective weakness and elevated CK obtained at admission was considered as myositis. History of dark urine, muscle tenderness, and swelling, serum potassium and serum creatinine were focused upon to rule out rhabdomyolysis. Urine myoglobin and Lactate dehydrogenase (LDH) were not performed because of their non-availability. None of the patients underwent a muscle biopsy.
Data were entered in an Excel sheet and analyzed using IBM SPSS22. Numerical data were analyzed by descriptive statistics. For continuous variables, independent samples T test was used to compare patients with and without S. paratyphi A bacteremia. Pearson correlation analysis was performed for the duration of symptoms, hospital stay, alcohol and tobacco use, LFT, renal function tests, CK, and hematological parameters. Statistical significance was defined as a P value <0.05.
| Results|| |
There were 19 patients with culture-positive S. paratyphi A, 18 being men. CK levels were missing in the lone female patient [Table 1]. Two instances of co-infection–one with scrub typhus and another with leptospirosis were found. Fifty percent presented with fever ≤1 week duration and 16 patients stayed >1 week in the hospital (mainly to complete a 7-day ceftriaxone course). Fourteen (14/42) had used alcohol and 7/42 smoked. CK elevations ranged between 1æ and 6 times normal (<170). Thrombocytopenia and alanine aminotransferase (ALT) elevations were seen in 47%. Complications such as acute kidney injury (AKI), cerebral edema, oral ulcers, earache (2/45, in the non-bacteremic group), pleurisy, dizziness (postural hypotension), and myocarditis/shock/upper gastrointestinal bleed (in the patient with leptospirosis+ typhoid fever) were observed. LDH (in patient no. 4) and urine myoglobin were not performed routinely because of its unavailability in our institution. All were negative for HIV.
|Table 1: Demography, clinical features, and investigations of patients with Salmonella paratyphi A bacteremia|
Click here to view
Thrombocytopenia, CK, CK-AST ratio, and longer hospital stay were significant in the bacteremic group [Table 2]. Duration of symptoms positively correlated with alcohol quantity (r = 710; P < 0.001) and with elevations in alkaline phosphatase (r = 0.636; P < 0.001). Aspartate aminotransferase (AST) correlated positively with total leukocyte count (r = 0.321; P = 0.043), while alanine aminotransferase (ALT) negatively correlated with both De Ritis ratio and CK-AST ratio (r = 516; P = 0.001 and r = 326; P = 0.37). The De Ritis ratio had a significant positive correlation with both the CK-AST ratio (r = 0.436; P = 0.004) and creatinine (r = 0.325; P = 0.02). Patient no. 18 had cerebral edema necessitating mannitol for 48 hours. All 19 patients received 7 days of ceftriaxone and needed 4–5 days for defervescence. Because all our isolates were sensitive to both ampicillin and cotrimoxazole, patients were additionally, given a 7-day course of the latter. Patients who had been initiated on azithromycin at admission for prominent respiratory symptoms or signs were not given cotrimoxazole. One patient with diabetes mellitus, received ceftriaxone for 14 days because defervescence occurred only on the 12th day. We could not localize any focal abscesses in him. All patients received advice regarding eating street food, hygienic practices, and safe sanitation.
|Table 2: Comparison of clinical and laboratory data between the two groups|
Click here to view
| Discussion|| |
Enteric fever is the most significant clinical manifestation of S. enterica. S. paratyphi contributes to >5 million cases/year, globally. In 2005, the incidence of S. paratyphi to S. typhi compared among study populations in India, China, Indonesia, and Pakistan indicated that S. paratyphi contributed to a significant percentage of cases. The incidence in South Asia is 40–80 cases/100,000 person-years and is increasing where the disease burden is high. In 1975, S. paratyphi was reported to be the third most common, while S. typhi constituted 57% of the 47 human serotypes at that time. The prevalence of paratyphoid fever is most commonly reported with S paratyphi A. The prevalence of S paratyphi A has been less than 8% in most study sites. There is a seasonal trend in incidence of enteric fever in Asia, peaking between May and October that are the most warm months of the year that may lead to higher growth of bacteria on food and corresponds to people searching for food or drinks as refreshments during these months. Hot weather and water scarcity may also lead to ingesting of contaminated water and drinks. In a retrospective study from Nepal, blood culture data over 23 years revealed that S paratyphi A constituted 30% of all isolates of the S. enterica subspecies I. The Indian burden of paratyphoid fever is >100/100,000 person-years. Southern and Western India have a greater burden than that of Northern and Eastern India. S. paratyphi has been isolated from 50% of returning travelers (with enteric fever) from the Indian subcontinent. In our own institution (2011–2014), S. paratyphi constituted 50.8% of Salmonella isolates; in 2014, S. paratyphi contributed to a staggering 91.3% of isolates. In a study from Chennai over a 2-year period, 134/322 Salmonella isolates were of S. paratyphi A. In Karnataka, ≥50% isolates were because of S. paratyphi and a seasonal increase (monsoon) was also observed. In hospital-based studies, 10–54.5% of enteric fever cases are attributable to paratyphoid fever.
Clinical features of paratyphoid infection are often indistinguishable from typhoid fever. Myalgia is seen in 20% and arthralgia in <5% of patients with enteric fever. Myalgia was universal in our setting; additionally, mild encephalopathic changes such as confusion or apathy were also observed. Musculoskeletal problems such as osteomyelitis, myositis, and abscesses have been described only as case reports. Myositis is muscle inflammation due to both infectious and non-infectious (metabolic, inflammatory, and genetic) causes. Infectious myositis is classified into non-pyogenic generalized (the focus of our study) and pyogenic focal types. Infection-related myositis occurs due to viral (influenza), bacterial (tropical myositis), mycobacterial (tuberculosis), fungal (candidiasis), and parasitic (toxoplasmosis) diseases. Bacteria and fungi are more likely to cause focal myositis. Myositis due to Salmonella species is rare and has been reported with S. typhi and S. enteritidis. Myalgia, with or without myositis. is observed in rickettsial fevers (scrub typhus), leptospirosis, dengue, HIV infection, Lyme disease, and infective endocarditis; the first three are common in a tropical setting like ours. We had one case of scrub typhus and leptospirosis each co-existing with enteric fever. More >50% Salmonella-related pyomyositis are due to S. enteritidis species. Collazos et al., had compiled 31 cases of Salmonella-related focal muscle infections reported between 1962 and 1999. Diabetes mellitus, HIV infection, alcoholism, cancer chemotherapy, steroid use, and trauma are common predisposing factors for pyomyositis., S. typhi-related pyomyositis has been described in an immunocompetent male from India. Naidoo et al., described four people with typhoid polymyositis, with three from the same family and suggested a genetic predisposition. Other focal extraintestinal abscesses arising due to S paratyphi infections such as the breast and kidneys have also been reported, all of them being in young adults., Only one case of S. paratyphi B-related myositis and rhabdomyolysis has been reported, but this patient also had hepatitis and disseminated intravascular coagulation. Mechanisms of myositis/rhabdomyolysis include bacterial invasion of the muscle, sepsis-related tissue hypoxia, and altered metabolic capacity of the muscle.
Under-reporting of myositis probably occurs because CK is not a routinely performed test in febrile patients unless weakness, calf pain, or cola-colored urine is present, or when leptospirosis is part of the differential diagnosis. Mirsadraee et al., reported that AST correlated more with CK levels rather than liver disease, thereby proposing that the transaminase elevations in typhoid fever may be due to muscular origin. In our series, CK correlated significantly with both the De Ritis ratio (r = 0.786; P < 0.001) and CK-AST ratio (r = 0.436; P = 0.04). Most of our patients had both CK and ALT elevations, while only 10 had increases in AST.
One reason attributed to the increasing incidence of S. paratyphi is the probable use of vaccines that predominantly protects against S. typhi. No vaccination history was available even though cross-protection may exist for some vaccines such as Ty21avv. Vaccines for S. paratyphi are currently not available. We did not have the facility for LDH and urine myoglobin, so rhabdomyolysis could not be confirmed. The sample size was small, and data were from a single medical unit. We did not have access to data from the other four medical units and the Pediatrics department. A surveillance model similar to the Chinese National Infections Disease Surveillance System may improve data collections.
| Conclusions|| |
Fever and severe myalgia in a tropical country like India bring to mind leptospirosis, rickettsioses, dengue, and other viral fevers. Enteric fever is not usually considered in the differential diagnosis of myalgia with elevated CK in the tropics. Salmonella infections have been described in literature as a cause of focal myositis, while our patients appeared to have diffuse myositis associated with enteric fever. Although only one report of paratyphoid fever has been shown to cause myositis, because of our findings, it is possible that myositis in enteric fever may have been unrecognized, and therefore, under-reported. Thus, physicians need to be aware of enteric fever-associated myositis that appears to be common in bacteremic patients. However, we are amid a paratyphoid epidemic, one should remember that myalgia could be a harbinger of S. paratyphi infection and myositis may be more frequently seen than not.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Teh CS, Chua KH, Thong KL. Paratyphoid fever: Splicing the global analyses. Int J Med Sci 2014;11:732-41.
Franco-Paredes C, Khan MI, Gonzalez-Diaz E, Santos-Preciado JI, Rodriguez-Morales AJ, Gotuzzo E, et al.
Enteric fever: A slow response to an old plague. PLoS Negl Trop Dis 2016;10:e0004597.
Collazos J, Mayo J, Martínez E, Blanco MS. Muscle infections caused by Salmonella
species: Case report and review. Clin Infect Dis 1999;29:673-7.
Myositis of the rectus abdominis after typhoid fever. Lancet 1904;163:593-4. [doi: 10.1016/S0140-6736(00)65900-7].
Khan FY, Al-Ani A, Ali HA. Typhoid rhabdomyolysis with acute renal failure and acute pancreatitis: A case report and review of the literature. Int J Infect Dis 2009;13:e282-5.
Martin LB, Simon R, MacLennan CA, Tennant SM, Sahastrabuddhe S, Khan MI, et al.
Status of paratyphoid fever vaccine research and development. Vaccine 2016;34:2900-2.
Harris JB, Ryan ED. Enteric fever and other causes of fever and abdominal symptoms. In: Douglas and Bennett's Principles and Practice of Infectious Diseases. 8th
ed. Bennett JE, Dolin R, Blaser MJ. Mandell (editors). Philadelphia: Elsevier, 2015. p. 1270-82.
Ochiai RL, Wang X, von Seidlein L, Yang J, Bhutta ZA, Bhattacharya SK, et al. Salmonella
paratyphi A rates, Asia. Emerg Infect Dis 2005;11:1764-6.
Vidyalakshmi K, Yashavanth R, Chakrapani M, Shrikala B, Bharathi B, Suchitra U, et al.
Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008;38:89-91.
Basu S, Dewan ML, Suri JC. Prevalence of Salmonella
serotypes in India: A 61-year study. Bull World Health Organ 1975;52:331-6.
Als D, Radhakrishnan A, Arora P, Gaffey MF, Campisi S, Velummailum R, et al.
Global trends in typhoidal salmonellosis: A systematic review. Am J Trop Med Hyg 2018. [Epub ahead of print].
Saad NJ, Lynch VD, Antillón M, Yang C, Crump JA, Pitzer VE, et al.
Seasonal dynamics of typhoid and paratyphoid fever. Sci Rep 2018;8:6870.
Zellweger RM, Basnyat B, Shrestha P, Prajapati KG, Dongol S, Sharma PK, et al.
A23-year retrospective investigation of Salmonella
typhi and Salmonella
paratyphi isolated in a tertiary Kathmandu hospital. PLoS Negl Trop Dis 2017;11:e0006051.
John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: Systematic review and meta-analysis. PLoS Negl Trop Dis 2016;10:e0004616.
Arndt MB, Mosites EM, Tian M, Forouzanfar MH, Mokhdad AH, Meller M, et al.
Estimating the burden of paratyphoid a in Asia and Africa. PLoS Negl Trop Dis 2014;8:e2925.
Fangtham M, Wilde H. Emergence of Salmonella
paratyphi A as a major cause of enteric fever: Need for early detection, preventive measures, and effective vaccines. J Travel Med 2008;15:344-50.
Jayavarthinni M, Madhusudhan NS, Dhanaleha P, Sivagamsundari D. Emergence of Salmonella paratyphi a and submergence of Salmonella typhi and their trend over four years. Ann Int Med Dent Res 2016;2:7-10.
Choudhary A, Gopalakrishnan R, Nambi PS, Ramasubramanian V, Ghafur KA, Thirunarayan MA, et al.
Antimicrobial susceptibility of Salmonella enterica
serovars in a tertiary care hospital in Southern India. Indian J Med Res 2013;137:800-2.
] [Full text]
Anegundi R, Banerjee B, Mukhopadhyay C, Nishanth A, Shyamasunder Bhat N. Finding Salmonella
in unusual sites: Look before you leap. A case series. Trop Doct 2018;48:127-31.
Tarkowski A. Infection and musculoskeletal conditions: Infectious arthritis. Best Pract Res Clin Rheumatol 2006;20:1029-44.
Crum-Cianflone NF. Infection and musculoskeletal conditions: Infectious myositis. Best Pract Res Clin Rheumatol 2006;20:1083-97.
Kallen PS, Louie JS, Nies KM, Bayer AS. Infections myositis and related syndromes. Semin Arthritis Rheum 1982;11:421-39.
Hsu CC, Chen WJ, Chen SY, Chiang WC, Hsueh PR. Fatal septicemia and pyomyositis caused by Salmonella
typhi. Clin Infect Dis 2004;39:1547-9.
Phadke PS, Gandhi AR, More SA, Joshirao RP. Salmonella
pyomyositis with concurrent sacroiliac osteomyelitis presenting as piriformis syndrome: A rare case. J Postgrad Med 2017;63:44-6.
] [Full text]
Naidoo PM, Yan CC. Typhoid polymyositis. S Afr Med J 1975;49:1975-6.
Agrawal S, Yadav VS, Srivastava A, Kapil A, Dhawan B. Breast abscess due to Salmonella
paratyphi A: Case reports with review of literature. Intractable Rare Dis Res 2018;7:130-3.
Sirmatel F, Balci I, Sirmatel O, Bayazit N, Hocaoglu S. A case of Salmonella
paratyphi B septicaemia complicated by disseminated intravascular coagulation, severe hepatitis rhabdomyolysis and acute renal failure. J Infect 2001;43:19.
Fisk DT, Bradley SF. Rhabdomyolysis induced by Salmonella enterica
serovar typhi bacteraemia. Clin Microbiol Infect 2004;10:595-7.
Mirsadraee M, Shirdel A, Roknee F. Typhoid myopathy or typhoid hepatitis: A matter of debate. Indian J Med Microbiol 2007;25:351-3.
] [Full text]
Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A. Specific and cross-reactive immune response to oral Salmonella
typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Vaccine 2015;33:451-8.
[Table 1], [Table 2]